appScorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Venus Remedies Ltd
VENUSREM
Price Chart
Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key MetricsEdit
Forecast & RatingsDetailed Forecast
Company Profile
Venus Remedies Limited is engaged in pharmaceutical product manufacturing business. The Company provides formulations and manufactures dosage injectables.
PeersCompare with peers
Sun Pharmaceutical Industries Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Torrent Pharmaceuticals Ltd
Mankind Pharma Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Holdings TrendDetailed holdings
Low Pledged Promoter HoldingLower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
Mutual Fund HoldingIncreasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has almost stayed constant
Recent NewsAll news
Venus Remedies gets GMP certification from Kenya for production facilities in Baddi
6 days ago•Moneycontrol
DSIR Recognition to Venus Remedies’ in-house R&D Unit
1 week ago•Economic Times
Venus Remedies Gets Market Authorisation From Philippines, Iraq For Two More Cancer Drugs
2 weeks ago•Bloomberg Quint
Recent EventsAll events
Press Release
Venus Remedies Limited has informed the Exchange regarding a press release dated May 23, 2023, titled "Venus Remedies secures Kenyan GMP certification for all its manufacturing facilities in Baddi". | Download
Venus Remedies Limited has informed the Exchange regarding a press release dated May 23, 2023, titled "Venus Remedies secures Kenyan GMP certification for all its manufacturing facilities in Baddi". | Download
Cash Dividend
Final • Div/Share: ₹ 3
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant